Autolus Therapeutics (AUTL) EBT (2017 - 2025)
Historic EBT for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to -$78.6 million.
- Autolus Therapeutics' EBT rose 424.75% to -$78.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$220.2 million, marking a year-over-year increase of 1850.58%. This contributed to the annual value of -$219.1 million for FY2024, which is 514.97% down from last year.
- According to the latest figures from Q3 2025, Autolus Therapeutics' EBT is -$78.6 million, which was up 424.75% from -$47.5 million recorded in Q2 2025.
- In the past 5 years, Autolus Therapeutics' EBT ranged from a high of -$7.4 million in Q4 2022 and a low of -$39.4 billion during Q3 2021
- Over the past 5 years, Autolus Therapeutics' median EBT value was -$45.5 million (recorded in 2023), while the average stood at -$2.1 billion.
- Per our database at Business Quant, Autolus Therapeutics' EBT tumbled by 8705360.78% in 2021 and then soared by 9989.14% in 2022.
- Over the past 5 years, Autolus Therapeutics' EBT (Quarter) stood at -$24.1 million in 2021, then surged by 69.23% to -$7.4 million in 2022, then crashed by 939.1% to -$77.2 million in 2023, then surged by 66.13% to -$26.1 million in 2024, then tumbled by 200.59% to -$78.6 million in 2025.
- Its EBT stands at -$78.6 million for Q3 2025, versus -$47.5 million for Q2 2025 and -$67.9 million for Q1 2025.